Efficacy and safety of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer: Real-world data

被引：1

作者：

Rached, L. W. ^{[1
]}

Spotti, M. P. ^{[1
]}

Baldini, C. ^{[2
]}

Laparra, A. ^{[3
]}

Remote, C. A. Dutertre ^{[4
]}

Sakkal, M. ^{[5
]}

Perret, A. ^{[6
]}

Viansone, A. A. ^{[1
]}

Zeghondy, J. Z. ^{[6
]}

Rassy, E. ^{[7
]}

Bousrih, C. ^{[1
]}

Abdayem, P. ^{[8
]}

Abboud, R. M. Khoury ^{[9
]}

El Masri, H. K. ^{[6
]}

Grinda, T. ^{[6
]}

Terencio, S. Moragon ^{[1
]}

Verret, B. ^{[6
]}

Champiat, S. ^{[2
]}

Pistilli, B. ^{[10
]}

Ribeiro, J. T. M. L. ^{[11
]}

机构：

[1] Inst Gustave Roussy, Dept Oncol, Villejuif, France

[2] Inst Gustave Roussy, Drug Dev Dept, DITEP, Villejuif, France

[3] Inst Gustave Roussy, DIOPP, Villejuif, France

[4] Gustave Roussy Canc Campus, Clin Res, Villejuif, France

[5] Gustave Roussy Canc Campus, Villejuif, France

[6] Inst Gustave Roussy, Med Oncol, Villejuif, France

[7] Inst Gustave Roussy, Adult Med Dept, Villejuif, France

[8] Gustave Roussy Canc Campus, Dept Canc Med, Villejuif, France

[9] Inst Gustave Roussy, Dept Hematol Oncol, Villejuif, France

[10] Inst Gustave Roussy, Breast Canc Grp, Villejuif, France

[11] Gustave Roussy Canc Campus, Breast Unit, Villejuif, France

来源：

关键词：

D O I：

10.1016/j.annonc.2023.09.460

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

263P

引用

页码：S288 / S288

页数：1